Sensus Healthcare Inc. (SRTS)
Sensus Healthcare Statistics
Share Statistics
Sensus Healthcare has 16.45M shares outstanding. The number of shares has increased by 0.63% in one year.
| 16.45M |
| 0.63% |
| 0.64% |
| 30.06% |
| 13.51M |
| 2,397 |
| 2.41% |
Short Selling Information
The latest short interest is 898.55K, so 5.46% of the outstanding shares have been sold short.
| 898.55K |
| 5.46% |
| 6% |
| 9.13 |
Valuation Ratios
The PE ratio is 16.98 and the forward PE ratio is 10.04. Sensus Healthcare's PEG ratio is 0.01.
| 16.98 |
| 10.04 |
| 2.7 |
| 1.1 |
| 2.02 |
| -101.97 |
| 0.01 |
Enterprise Valuation
Sensus Healthcare has an Enterprise Value (EV) of 91.43M.
| 2.19 |
| 10.73 |
| -110.02 |
| -82.59 |
Financial Position
The company has a current ratio of 9.64, with a Debt / Equity ratio of 0.01.
| 9.64 |
| 7.93 |
| 0.01 |
| 0.07 |
| -0.54 |
| 0 |
Financial Efficiency
Return on Equity is 11.91% and Return on Invested Capital is 10.51%.
| 11.91% |
| 10.69% |
| 10.51% |
| $774,203.7 |
| $123,092.59 |
| 54 |
| 0.67 |
| 1.72 |
Taxes
| 2.38M |
| 26.32% |
Stock Price Statistics
The stock price has increased by -7.66% in the last 52 weeks. The beta is 1.32, so Sensus Healthcare's price volatility has been higher than the market average.
| 1.32 |
| -7.66% |
| 4.66 |
| 6.02 |
| 50.36 |
| 99,442 |
Income Statement
In the last 12 months, Sensus Healthcare had revenue of 41.81M and earned 6.65M in profits. Earnings per share was 0.41.
| 41.81M |
| 24.43M |
| 8.09M |
| 6.65M |
| 8.52M |
| 8.09M |
| 0.41 |
Balance Sheet
The company has 22.06M in cash and 602K in debt, giving a net cash position of 21.45M.
| 22.06M |
| 602K |
| 21.45M |
| 13.43M |
| 60.21M |
| 47.47M |
Cash Flow
In the last 12 months, operating cash flow was -831K and capital expenditures -276K, giving a free cash flow of -1.11M.
| -831K |
| -276K |
| -1.11M |
| -0.07 |
Margins
Gross margin is 58.44%, with operating and profit margins of 19.35% and 15.9%.
| 58.44% |
| 19.35% |
| 21.58% |
| 15.9% |
| 20.38% |
| 19.35% |
| -2.65% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| 5.89% |
| -0.98% |
Analyst Forecast
The average price target for SRTS is $12, which is 149% higher than the current price. The consensus rating is "Buy".
| $12 |
| 149% |
| Buy |
| 3 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| 5.6 |
| 16.18% |
Scores
| 8.55 |
| 5 |